RxDoctor Payments Data

Jacob Hunter, MD

Otology & Neurotology · Philadelphia, PANPI 1053644963

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Med-el Corporation at 48.4% of the total.

$110,818in general payments, 2019–2025

Across 174 payments — averaging $636.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$54K
  • Medtronic$34K
  • Cochlear Americas$11K
  • Oticon Medical, LLC$8K
  • Iotamotion, Inc.$2K
  • Advanced Bionics, LLC$2K
  • plus $467 from 6 others
$50,370in research payments, 2019–2025

Across 4 payments — averaging $12,592 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Advanced Bionics, LLC$24K
  • Med-el Corporation$23K
  • Cochlear Americas$3K

What the payments were for

  • Consulting fees$9,2228%
  • Speaking & faculty fees$52,05147%
  • Travel & lodging$40,23536%
  • Food & beverage$8,9478%
  • Education$3640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Med-el Corporation83$53,654
Medtronic(2 entities)26$33,952
Cochlear Americas37$11,166
Oticon Medical, LLC3$8,071
Iotamotion, Inc.5$1,816
Advanced Bionics, LLC12$1,693
Heron Therapeutics, Inc.1$122
Olympus America Inc.1$119
Globus Medical1$101
Stryker2$56
Inspire Medical Systems, Inc.2$40
Merck1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$113,932
Medicare patients
372
Services billed
722

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl54$1,703
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,378
Ofloxacin50$1,029
Nortriptyline Hcl48$864
Propranolol Hcl16$527
Fluticasone Propionate33$474
Verapamil ErVerapamil Hcl12$190
Venlafaxine Hcl ErVenlafaxine Hcl20$159
Prednisone20$56
Cephalexin12$53

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →